Show simple item record

dc.contributor.authorPalou, E.Y.
dc.contributor.authorRamos, M.A.
dc.contributor.authorCherenfant, E.
dc.contributor.authorDuarte, A.
dc.contributor.authorFuentes-Barahona, I.C.
dc.contributor.authorZambrano, L.I.
dc.contributor.authorMuñoz-Lara, F.
dc.contributor.authorMontoya-Ramirez, S.A.
dc.contributor.authorCardona-Ortiz, A.F.
dc.contributor.authorValle-Reconco, J.A.
dc.contributor.authorMontenegro-Idrogo, J.J.
dc.contributor.authorBonilla-Aldana, D.K.
dc.contributor.authorPaniz-Mondolfi, A.E.
dc.contributor.authorRodriguez-Morales, A.J.
dc.date.accessioned2025-10-31T18:32:17Z
dc.date.available2025-10-31T18:32:17Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/20.500.12805/4575
dc.description.abstractBackground: Mucormycosis is a life-threatening invasive fungal infection most commonly observed in immunocompromised patients. Throughout the COVID-19 pandemic, a growing number of Mucorales associated infections, now termed COVID-19 associated mucormycosis (CAM), have been reported. Despite an increase in fatality reports, no cases of rhino-orbital CAM complicated with gangrenous bone necrosis have been described in the literature to date. Case: A 56-year-old male with a recent COVID-19 diagnosis developed rhino-orbital mucormycosis after 22 days of treatment with dexamethasone. Cultures and histopathological assessment of tissue biopsy confirmed the diagnosis. The patient survived after treatment with amphotericin B. Conclusions: Mucormycosis is an invasive fungal infection affecting mostly immunocompromised patients. Along with the COVID-19 pandemic, the inappropriate use of steroids, in addition to concurrent risk factors, such as diabetes, has led to an increase in the occurrence of these devastating mycoses, leading to the development of severe presentations and complications, as observed in many cases. Early diagnosis and prompt treatment are crucial in order to avoid dissemination and fatal outcomes.en_US
dc.description.sponsorshipThe Facultad de Ciencias Médicas (FCM) (2-03-01-01), National Autonomous University of Honduras, Tegucigalpa, MDC, Honduras, supported the publication fees of this article. L.I.Z.
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofurn:issn:2076-393X
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectInvasive Fungal Infections and Antifungal Resistanceen_US
dc.subjectMucormycosis: Emerging Fungal Infections and Treatmentsen_US
dc.titleCovid-19 associated rhino-orbital mucormycosis complicated by gangrenous and bone necrosis—a case report from hondurasen_US
dc.typehttps://purl.org/coar/resource_type/c_0857
dc.identifier.doihttps://doi.org/10.3390/vaccines9080826
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.05
dc.type.otherCommunication letter o Case Report
dc.identifier.journalVaccines
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2